<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T09:14:08Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6893799" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6893799</identifier>
        <datestamp>2019-12-23</datestamp>
        <setSpec>nutrients</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Nutrients</journal-id>
              <journal-id journal-id-type="iso-abbrev">Nutrients</journal-id>
              <journal-id journal-id-type="publisher-id">nutrients</journal-id>
              <journal-title-group>
                <journal-title>Nutrients</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2072-6643</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6893799</article-id>
              <article-id pub-id-type="pmcid">PMC6893799</article-id>
              <article-id pub-id-type="pmc-uid">6893799</article-id>
              <article-id pub-id-type="pmid">31703434</article-id>
              <article-id pub-id-type="doi">10.3390/nu11112697</article-id>
              <article-id pub-id-type="publisher-id">nutrients-11-02697</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effects of Duodenal Infusion of Lauric Acid and L-Tryptophan, Alone and Combined, on Fasting Glucose, Insulin and Glucagon in Healthy Men</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>McVeay</surname>
                    <given-names>Christina</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fitzgerald</surname>
                    <given-names>Penelope C. E.</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Horowitz</surname>
                    <given-names>Michael</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6848-0125</contrib-id>
                  <name>
                    <surname>Feinle-Bisset</surname>
                    <given-names>Christine</given-names>
                  </name>
                  <xref rid="c1-nutrients-11-02697" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="af1-nutrients-11-02697">Adelaide Medical School, Centre of Research Excellence in Translating Nutritional Science to Good Health, Level 5 Adelaide Health and Medical Sciences Building, Corner North Terrace and George Street, Adelaide 5005, Australia; <email>christina.mcveay@adelaide.edu.au</email> (C.M.); <email>penelope.fitzgerald@adelaide.edu.au</email> (P.C.E.F.); <email>michael.horowitz@adelaide.edu.au</email> (M.H.)</aff>
              <author-notes>
                <corresp id="c1-nutrients-11-02697"><label>*</label>Correspondence: <email>christine.feinle@adelaide.edu.au</email>; Tel.: +61-8-8313-6053</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>07</day>
                <month>11</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>11</month>
                <year>2019</year>
              </pub-date>
              <volume>11</volume>
              <issue>11</issue>
              <elocation-id>2697</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>9</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>06</day>
                  <month>11</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2019 by the authors.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license license-type="open-access">
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>The fatty acid, lauric acid (‘C12’), and the amino acid, tryptophan (‘Trp’), when given intraduodenally at loads that individually do not affect energy intake, have recently been shown to stimulate plasma cholecystokinin, suppress ghrelin and reduce energy intake much more markedly when combined. Both fatty acids and amino acids stimulate insulin secretion by distinct mechanisms; fatty acids enhance glucose-stimulated insulin secretion, while amino acids may have a direct effect on pancreatic β cells. Therefore, it is possible that, by combining these nutrients, their effects to lower blood glucose may be enhanced. We have investigated the potential for the combination of C12 and Trp to have additive effects to reduce blood glucose. To address this question, plasma concentrations of glucose, insulin and glucagon were measured in 16 healthy, lean males during duodenal infusions of saline (control), C12 (0.3 kcal/min), Trp (0.1 kcal/min), or C12+Trp (0.4 kcal/min), for 90 min. Both C12 and C12+Trp moderately reduced plasma glucose compared with control (<italic>p</italic> &lt; 0.05). C12+Trp, but not C12 or Trp, stimulated insulin and increased the insulin-to-glucose ratio (<italic>p</italic> &lt; 0.05). There was no effect on plasma glucagon. In conclusion, combined intraduodenal administration of C12 and Trp reduced fasting glucose in healthy men, and this decrease was driven primarily by C12. The effects of these nutrients on postprandial blood glucose and elevated fasting blood glucose in type 2 diabetes warrant evaluation.</p>
              </abstract>
              <kwd-group>
                <kwd>amino acid</kwd>
                <kwd>fatty acid</kwd>
                <kwd>glycaemic control</kwd>
                <kwd>blood glucose</kwd>
                <kwd>humans</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-nutrients-11-02697">
              <title>1. Introduction</title>
              <p>Fat or protein, when consumed immediately before a carbohydrate-containing meal, may reduce the postprandial glycaemic excursion in health and type 2 diabetes substantially [<xref rid="B1-nutrients-11-02697" ref-type="bibr">1</xref>,<xref rid="B2-nutrients-11-02697" ref-type="bibr">2</xref>,<xref rid="B3-nutrients-11-02697" ref-type="bibr">3</xref>]. The slowing of gastric emptying and the release of gut hormones, particularly the incretin hormone, glucagon-like peptide-1 (GLP-1), are central to this effect [<xref rid="B4-nutrients-11-02697" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-11-02697" ref-type="bibr">5</xref>]. The slowing of gastric emptying reflects, at least in part, the stimulation of pyloric contractile activity as a result of inhibitory feedback arising from the presence of nutrients in the small intestine [<xref rid="B6-nutrients-11-02697" ref-type="bibr">6</xref>]. There is considerable variation between nutrients in their effects to stimulate gut and glucoregulatory hormones; fat appears to be a more potent stimulant of GLP-1 than protein, whereas protein appears to have greater effects on insulin and glucagon [<xref rid="B7-nutrients-11-02697" ref-type="bibr">7</xref>,<xref rid="B8-nutrients-11-02697" ref-type="bibr">8</xref>]. Fatty acids enhance glucose-stimulated insulin secretion [<xref rid="B9-nutrients-11-02697" ref-type="bibr">9</xref>], while amino acids may have a direct effect on pancreatic β cells to simulate insulin release independent of glucose [<xref rid="B10-nutrients-11-02697" ref-type="bibr">10</xref>].</p>
              <p>In this context, lauric acid, a fatty acid containing 12 carbon atoms (‘C12’), and tryptophan (‘Trp’), an aromatic amino acid, are of particular interest [<xref rid="B11-nutrients-11-02697" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-11-02697" ref-type="bibr">12</xref>,<xref rid="B13-nutrients-11-02697" ref-type="bibr">13</xref>], since both potently stimulate pyloric contractile activity and gut hormones. For example, Trp, when administered intraduodenally at a dose of 0.15 kcal/min, but not 0.075 kcal/min, stimulated plasma insulin, glucagon and GLP-1 concentrations modestly, but had no effect on blood glucose in healthy males [<xref rid="B11-nutrients-11-02697" ref-type="bibr">11</xref>], while intragastric administration of 3 g, but not 1.5 g, of Trp attenuated the blood glucose response to a mixed-nutrient drink in lean and obese participants [<xref rid="B13-nutrients-11-02697" ref-type="bibr">13</xref>]. In people with type 2 diabetes, C12, when delivered to the distal small intestine in enteric-coated capsules prior to meals, lowered postprandial blood glucose and stimulated GLP-1, but did not stimulate insulin [<xref rid="B14-nutrients-11-02697" ref-type="bibr">14</xref>]. Accordingly, blood glucose lowering may reflect the stimulation of GLP-1 receptors on portal vagal afferents [<xref rid="B15-nutrients-11-02697" ref-type="bibr">15</xref>], to enhance hepatic and peripheral glucose uptake [<xref rid="B16-nutrients-11-02697" ref-type="bibr">16</xref>].</p>
              <p>It is thought that C12 and Trp stimulate gut and glucoregulatory hormones via distinct populations of receptors located on enteroendocrine cells [<xref rid="B17-nutrients-11-02697" ref-type="bibr">17</xref>,<xref rid="B18-nutrients-11-02697" ref-type="bibr">18</xref>,<xref rid="B19-nutrients-11-02697" ref-type="bibr">19</xref>]; therefore, it would not be surprising if the combination of these nutrients would enhance their individual effects to lower blood glucose. In support of this hypothesis, C12 and Trp, when given intraduodenally at loads that individually do not affect energy intake, reduce energy intake substantially when combined, associated with much greater stimulation of cholecystokinin (CCK) and suppression of ghrelin, in healthy males [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>]. In contrast, while C12 stimulated GLP-1, this effect was not augmented when C12 and Trp were combined. Given the important role of GLP-1 in blood glucose regulation, as discussed above, this latter finding suggests, however, that C12 and Trp, in contrast to their effects on energy intake, may not have additive effects to lower blood glucose.</p>
              <p>We have now investigated the potential for the combination of C12 and Trp to reduce fasting blood glucose more than each nutrient individually. We assayed samples from our previous study to quantify plasma concentrations of glucose, insulin and glucagon [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>].</p>
            </sec>
            <sec id="sec2-nutrients-11-02697">
              <title>2. Materials and Methods</title>
              <sec id="sec2dot1-nutrients-11-02697" sec-type="subjects">
                <title>2.1. Study Participants</title>
                <p>As described in the primary publication [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>], 16 healthy, lean mean (mean age: 24 ± 1.5 years; body mass index (BMI): 22.9 ± 0.4 kg/m²) were included. Participants were recruited, as described previously [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>]. All participants had been weight-stable and were unrestrained eaters (score ≤12 on the eating restraint section (Factor 1) of the Three-Factor Eating Questionnaire [<xref rid="B21-nutrients-11-02697" ref-type="bibr">21</xref>]). None had a history of gastrointestinal (GI) symptoms or surgery, used supplements or medications known to affect GI function or appetite, smoked, consumed &gt;20 g/d of alcohol, or were vegetarians. Once enrolled into the study, each participant was allocated a random treatment sequence based on balanced randomisation generated using an online tool (<uri xlink:href="www.randomization.com">www.randomization.com</uri>), by an investigator who was not involved in data analysis (P.C.E.F.). Both the participant and the investigator who assessed outcomes (C.M.) were blinded to the randomisation. The Human Research Ethics Committee of the Central Adelaide Local Hospital Network approved the study protocol, and all participants provided informed, written consent prior to their inclusion. The study was registered as a clinical trial at the Australian and New Zealand Clinical Trial Registry (<uri xlink:href="www.anzctr.org.au">www.anzctr.org.au</uri>, trial number: ANZCTR 12613000899741).</p>
              </sec>
              <sec id="sec2dot2-nutrients-11-02697">
                <title>2.2. Study Design and Protocol</title>
                <p>Comprehensive information about the design of the study, which was a randomised, double-blind, cross-over design, including the participant enrolment flow diagram, has been published [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>]. Briefly, each participant was studied on four separate days, 3–10 days apart, to evaluate the effect of intraduodenal administration of (1) lauric acid (‘C12’; load: 27 kcal, 0.3 kcal/min), (2) L-tryptophan (‘Trp’; load: 9 kcal, 0.1 kcal/min), (3) a combination of C12 and Trp (‘C12+Trp’; load: 36 kcal, 0.4 kcal/min), or (4) control (isotonic saline) on fasting plasma glucose, insulin and glucagon concentrations. The choice of nutrient loads was based on our previous studies, which had established sub-maximal effects on gut hormones, and doses were less than those shown to suppress energy intake [<xref rid="B11-nutrients-11-02697" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-11-02697" ref-type="bibr">12</xref>,<xref rid="B22-nutrients-11-02697" ref-type="bibr">22</xref>].</p>
                <p>After an overnight fast, participants attended our clinical laboratory in the morning at 8:00 am, and were intubated, via an anaesthetised nostril, with a manometry catheter used for monitoring antropyloroduodenal pressures and duodenal infusion of the treatment solutions [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>]. These were infused through a dedicated infusion port located ~14.5 cm beyond the pylorus. Once the catheter was in the correct position [<xref rid="B23-nutrients-11-02697" ref-type="bibr">23</xref>], and an intravenous cannula placed in an antecubital vein for blood sampling, two baseline blood samples (10 mL) were taken (<italic>t</italic> = −10 min and <italic>t</italic> = 0 min), during phase I of the migrating motor complex (a period of motor quiescence). Infusion of one of the nutrient solutions, or control, was then commenced and continued for 90 min (<italic>t</italic> = 0–90 min). During the infusion, blood samples were collected every 15 min. At <italic>t</italic> = 90 min, the infusion was ceased, the nasoduodenal catheter removed. The participant was offered a cold buffet-meal and instructed to consume as much as they wished until comfortably full (<italic>t</italic> = 90–120 min) [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>]. A final blood sample was taken at <italic>t</italic> = 120 min. The intravenous cannula was removed, and the participant was free to leave the laboratory.</p>
              </sec>
              <sec id="sec2dot3-nutrients-11-02697">
                <title>2.3. Control and Nutrient Treatments</title>
                <p>The solutions were prepared as follows: for the C12 solution, we used 5.55 g of food-grade lauric acid (C12:0) (Sigma-Aldrich, Milwaukee, WI, USA), 0.65 g NaOH and 4.5 g NaCl; for the Trp solution, we used 4.07 g crystalline, food-grade L-tryptophan (PureBulk Inc., Roseburg, OR, USA), 0.1 g NaOH and 4.1 g NaCl; for the C12+Trp solution, we used 5.55 g C12 and 4.07g crystalline L-tryptophan, 0.8 g NaOH and 3.8 g NaCl; for the control solution we used 4.9 g NaCl and 0.08 mL NaOH solution (prepared by dissolving 1.75 g NaOH in 250 mL water). All solutions were made to a final volume of 497 mL, were isotonic (~300 mOsm), had a pH of ~7.7-8.1 and were infused at a rate of 3 mL/min, so that 270 mL was the total volume administered in 90 min.</p>
              </sec>
              <sec id="sec2dot4-nutrients-11-02697">
                <title>2.4. Measurements</title>
                <sec>
                  <title>Plasma Glucose, Insulin and Glucagon Concentrations</title>
                  <p>Venous blood samples (10 mL) were collected into ice-chilled ethylenediaminetetraacetic acid-treated tubes. Plasma was separated by centrifugation at 3200 rpm for 15 min at 4 °C within 15 min of collection and stored at −80 °C until analysed, as described [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>].</p>
                  <p>Plasma glucose (mmol/L) was measured using a YSI2300 analyser (YSI, Inc., Yellow Springs, OH, USA). Intra- and inter-assay coefficient variations (CVs) were ≤2%.</p>
                  <p>Plasma insulin (mU/L) was determined by enzyme-linked immunosorbent assay (ELISA, 10-1113, Mercodia, Uppsala, Sweden). Intra- and inter-assay CVs were 2.4% and 9.5%, respectively. The detection limit was 1 mU/L.</p>
                  <p>Plasma glucagon (pg/mL) was quantified using an RIA (GL-32K, Millipore, Billerica, MA, USA). Intra- and inter-assay CVs were 3.2 and 6.1%, respectively. The detection limit was 20 pg/mL.</p>
                </sec>
              </sec>
              <sec id="sec2dot5-nutrients-11-02697">
                <title>2.5. Data and Statistical Analyses</title>
                <p>Power calculations were used to determine the number of participants, and indicated that <italic>n</italic> = 16 would allow detection of a 15% decrease in energy intake at α = 0.05 with a power of 80% [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>]. A secondary calculation indicated that this number would also allow detection of a 0.8 mmol/L difference in plasma glucose.</p>
                <p>Baseline (‘0’) values were calculated as the mean of values obtained at <italic>t</italic> = −10 and 0 min. Raw data of plasma glucose, insulin and glucagon concentrations were used to calculate areas under the curve (AUCs), from <italic>t</italic> = 0–90 min, using the trapezoidal rule. The insulin-to-glucose ratio was calculated, using AUCs for insulin and glucose from individual participants, with the following formula: insulin-to-glucose ratio = insulin AUC/glucose AUC. The plasma glucose nadir was determined as the lowest value during the infusion period.</p>
                <p>Statistical analyses were performed with SPSS software (version 24.0; SPSS Inc., IBM Corp, Somers, NY, USA). One-factor analysis of variance (ANOVA) was used for analyses of AUCs for glucose and hormone levels and insulin-to-glucose ratio, glucose nadir, and glucose and hormone concentrations at <italic>t</italic> = 120 min (i.e. immediately after the buffet-meal). For all ANOVAs, sphericity was evaluated by Mauchly’s test, and when violated, the adjusted Greenhouse–Geisser <italic>p</italic> value was reported. Normality assumption was met for all outcomes. Post hoc paired comparisons, adjusted for multiple comparisons by Bonferroni correction, were performed where ANOVAs were significant. Plasma glucose and hormone concentrations at <italic>t</italic> = 120 min were compared with concentrations at <italic>t</italic> = 90 min (i.e. before the buffet-meal) using paired <italic>t</italic>-tests. <italic>p</italic> values <italic>&lt;</italic> 0.05 were considered statistically significant, and all data were reported as means ± standard error of the mean (SEM).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-nutrients-11-02697">
              <title>3. Results</title>
              <p>The study treatments were well tolerated. Plasma insulin could not be measured in one participant due to technical problems. There were no significant differences in baseline plasma glucose, insulin or glucagon between study days.</p>
              <sec id="sec3dot1-nutrients-11-02697">
                <title>3.1. Plasma Glucose</title>
                <p>There was an effect of treatment on glucose AUC (<italic>p</italic> &lt; 0.01) (<xref rid="nutrients-11-02697-t001" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="nutrients-11-02697-f001">Figure 1</xref>A). C12 and C12+Trp, but not Trp, reduced the plasma glucose AUC compared with control (both <italic>p</italic> &lt; 0.05), with no significant differences between C12+Trp and C12 or Trp. There was an effect of treatment on nadir glucose (<italic>p</italic> &lt; 0.05) (<xref rid="nutrients-11-02697-t001" ref-type="table">Table 1</xref>), which was less during C12 and C12+Trp compared with control (all <italic>p</italic> &lt; 0.05), with no significant difference between nutrient treatments.</p>
                <p>Following the meal, plasma glucose increased when compared with <italic>t</italic> = 90 min (<italic>p</italic> &lt; 0.05), with no difference between treatments at <italic>t</italic> = 120 min.</p>
              </sec>
              <sec id="sec3dot2-nutrients-11-02697">
                <title>3.2. Plasma Insulin</title>
                <p>There was an effect of treatment on insulin AUC (<italic>p</italic> &lt; 0.05) (<xref rid="nutrients-11-02697-t001" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="nutrients-11-02697-f001">Figure 1</xref>B). C12+Trp, but not C12 or Trp, increased insulin AUC compared with control (<italic>p</italic> &lt; 0.05).</p>
                <p>Following the meal, insulin increased when compared with <italic>t</italic> = 90 min (<italic>p</italic> &lt; 0.05), with no difference between treatments at <italic>t</italic> = 120 min.</p>
              </sec>
              <sec id="sec3dot3-nutrients-11-02697">
                <title>3.3. Insulin-to-Glucose Ratio</title>
                <p>There was an effect of treatment on the insulin-to-glucose ratio (<italic>p</italic> &lt; 0.01) (<xref rid="nutrients-11-02697-t001" ref-type="table">Table 1</xref>), which was greater with C12+Trp, but not C12 or Trp, compared with control (<italic>p</italic> &lt; 0.01), with no significant differences between C12+Trp and C12 or Trp.</p>
              </sec>
              <sec id="sec3dot4-nutrients-11-02697">
                <title>3.4. Plasma Glucagon</title>
                <p>Plasma glucagon was not affected by the nutrient treatments (<xref rid="nutrients-11-02697-t001" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="nutrients-11-02697-f001">Figure 1</xref>C). Following the meal, glucagon was increased with Trp and C12+Trp, but not C12 or control, when compared with <italic>t</italic> = 90 min (<italic>p</italic> &lt; 0.05), with no difference between treatments at <italic>t</italic> = 120 min.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-nutrients-11-02697">
              <title>4. Discussion</title>
              <p>This study investigated the effects of intraduodenal administration of C12 and Trp, alone and in combination, on fasting plasma glucose, insulin and glucagon concentrations, in healthy men. Our data demonstrate that intraduodenal infusion of C12 modestly reduces plasma glucose, and that this effect was not further enhanced by its combination with Trp. This observation contrasts with the additive (and possibly synergistic) effects of C12 and Trp on energy intake and some GI hormones, whereby the combination of C12 and Trp, at loads that individually had no effect, substantially reduced energy intake, associated with markedly augmented release of CCK, and suppression of ghrelin, than observed in response to each nutrient alone [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>].</p>
              <p>Plasma glucose in response to C12 and C12+Trp, but not Trp, was lower compared with control, suggesting that glucose-lowering was driven by C12. The lack of effect of Trp on plasma glucose is consistent with findings from our previous studies with intraduodenal infusion of Trp at a slightly higher load of 0.15 kcal/min [<xref rid="B11-nutrients-11-02697" ref-type="bibr">11</xref>], or intragastric administration, where Trp at a dose of 3 g alone had no effect on fasting glucose, although it reduced postprandial glucose in both lean and obese individuals [<xref rid="B13-nutrients-11-02697" ref-type="bibr">13</xref>], possibly via slowing of gastric emptying, which is pivotal to the regulation of postprandial glycaemic control [<xref rid="B4-nutrients-11-02697" ref-type="bibr">4</xref>,<xref rid="B5-nutrients-11-02697" ref-type="bibr">5</xref>]. Our findings may appear to contradict results from animal studies. For example, in rats, a dose of 100 mg L-tryptophan/kg body weight was reported to lower fasting blood glucose levels [<xref rid="B24-nutrients-11-02697" ref-type="bibr">24</xref>]. It is, however, important to recognise that this dose corresponds to ~7 g in a 70 kg person, in contrast to the dose of ~2.2 g administered in the current study. We have previously reported that Trp, when given intraduodenally, at loads of &gt;4 g can induce nausea [<xref rid="B11-nutrients-11-02697" ref-type="bibr">11</xref>]. Thus, our findings probably do not contradict these earlier findings, which may represent responses to supraphysiological doses, but suggest that Trp, when administered at doses that are well tolerated by humans, and hence more physiological, does not affect fasting glucose concentrations. </p>
              <p>The mechanisms underlying the observed glucose lowering in response to these nutrients are unclear. Because insulin was higher, and the insulin-to-glucose ratio increased, with C12+Trp, but not significantly in response to C12 or Trp alone, glucose lowering by C12+Trp is likely to reflect, at least in part, insulin stimulation. Interestingly, although neither C12 nor Trp alone had any significant effect on insulin, mean levels were higher in response to both nutrients, although only C12 reduced blood glucose. Thus, other factors are likely to also be relevant.</p>
              <p>In an original analysis, we observed potent stimulation of GLP-1 by C12 and C12+Trp; in contrast, the effect of Trp was minor and not statistically significant [<xref rid="B20-nutrients-11-02697" ref-type="bibr">20</xref>]; while the incretin effect of GLP-1, i.e. the glucose-dependent potentiation of insulin secretion [<xref rid="B25-nutrients-11-02697" ref-type="bibr">25</xref>], may not apply to the current situation, because it requires circulating glucose concentrations of ~7–8 mmol/L [<xref rid="B26-nutrients-11-02697" ref-type="bibr">26</xref>], other studies have reported that lower glucose concentrations of ~4–5 mmol/L are sufficient [<xref rid="B27-nutrients-11-02697" ref-type="bibr">27</xref>]. Animal studies indicate that GLP-1 may also affect blood glucose via different mechanisms. GLP-1 receptors are present on neuronal cells in the hepatoportal system and central nervous system, and appear to contribute to the regulation of glucose homeostasis, independent of changes in insulin secretion [<xref rid="B28-nutrients-11-02697" ref-type="bibr">28</xref>]. Therefore, it is possible that GLP-1 acted in concert with insulin to lead to greater glucose suppression with C12 as well as C12+Trp.</p>
              <p>Because there was no differential effect on plasma glucagon, possibly involving suppression of glucagon by GLP-1, particularly during infusion of C12 and C12+Trp, an effect of glucagon to diminish the glucose-lowering effect of insulin can be ruled out.</p>
              <p>Some limitations of our study should be recognised. Only one dose of each nutrient was evaluated. Nutrients were administered intraduodenally so that the small intestinal delivery of nutrients was standardised and potential confounding effects of interindividual variations in gastric emptying were avoided, thus, the effects of intragastric or oral administration warrant investigation. There is increasing recognition of interrelations between glucose metabolism, dietary nutrients and the gut microbiome [<xref rid="B29-nutrients-11-02697" ref-type="bibr">29</xref>], and dietary changes have the capacity to alter the microbiome within 24 hours of introduction [<xref rid="B30-nutrients-11-02697" ref-type="bibr">30</xref>]. As we investigated the effects of only single doses, and very small amounts, of individual nutrients, our study was not designed to evaluate effects on the microbiome, and we would not expect these nutrients to have a major, if any, influence acutely; however, this warrants investigation in longer-term studies. Moreover, it would be of interest to evaluate whether the composition of the microbiome may influence the magnitude of glucose lowering in response to these nutrients across individuals. Only effects on fasting plasma glucose were evaluated. The study was performed in healthy people, because energy intake represented the primary study outcome. Given our observations of effects on blood glucose lowering in healthy people with good blood glucose control, we would expect more pronounced blood glucose lowering in people with type 2 diabetes with elevated fasting and postprandial blood glucose concentrations.</p>
            </sec>
            <sec sec-type="conclusions" id="sec5-nutrients-11-02697">
              <title>5. Conclusions</title>
              <p>The combined intraduodenal administration of C12 and Trp, in healthy men, modestly reduced fasting plasma glucose, an effect most likely driven by C12, and possibly involving both insulin and GLP-1. In light of the observed glucose-lowering effect, studies in healthy participants postprandially and in patients with type 2 diabetes are now warranted. If effective, these nutrients may potentially offer a novel, nutrient-based treatment option for the management of hyperglycaemia in people with type 2 diabetes.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>We are grateful to our biostatistician, Kylie Lange, The University of Adelaide, for statistical support, and to Scott Standfield and Judith Wishart for performing the hormone analyses.</p>
            </ack>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, C.F.-B. and M.H.; Data curation, C.M.; Formal analysis, C.M.; Funding acquisition, C.F.-B., Investigation, C.M. and P.C.E.F.; Methodology, C.F.-B.; Project administration, P.C.E.F. and C.F.-B.; Resources, C.F.-B.; Supervision, M.H., and C.F.-B.; Visualization, C.M.; Writing—original draft, C.M. and C.F.-B.; Writing—review and editing, C.M., M.H., and C.F.-B.</p>
            </notes>
            <notes>
              <title>Funding</title>
              <p>The research was supported by an NHMRC Project Grant (grant no. 1078471, 2015-19, to C.F.-B.). C.F.-B. was supported by an NHMRC Senior Research Fellowship (grant 1103020, 2016-21).</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest. The sponsors had no role in the design of the study, the collection, analyses, or interpretation of data, writing of the manuscript, and in the decision to publish the results.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-nutrients-11-02697">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gentilcore</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Chaikomin</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Russo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Rayner</surname>
                      <given-names>C.K.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2006</year>
                  <volume>91</volume>
                  <fpage>2062</fpage>
                  <lpage>2067</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2005-2644</pub-id>
                  <?supplied-pmid 16537685?>
                  <pub-id pub-id-type="pmid">16537685</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-nutrients-11-02697">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Stevens</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Cukier</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Maddox</surname>
                      <given-names>A.F.</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Clifton</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rayner</surname>
                      <given-names>C.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes</article-title>
                  <source>Diabetes Care</source>
                  <year>2009</year>
                  <volume>32</volume>
                  <fpage>1600</fpage>
                  <lpage>1602</lpage>
                  <pub-id pub-id-type="doi">10.2337/dc09-0723</pub-id>
                  <?supplied-pmid 19542012?>
                  <pub-id pub-id-type="pmid">19542012</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-nutrients-11-02697">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heer</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Egert</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Nutrients other than carbohydrates: Their effects on glucose homeostasis in humans</article-title>
                  <source>Diabetes Metab. Res. Rev.</source>
                  <year>2015</year>
                  <volume>31</volume>
                  <fpage>14</fpage>
                  <lpage>35</lpage>
                  <pub-id pub-id-type="doi">10.1002/dmrr.2533</pub-id>
                  <?supplied-pmid 24510463?>
                  <pub-id pub-id-type="pmid">24510463</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-nutrients-11-02697">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Edelbroek</surname>
                      <given-names>M.A.L.</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Straathof</surname>
                      <given-names>J.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects</article-title>
                  <source>Diabetologia</source>
                  <year>1993</year>
                  <volume>36</volume>
                  <fpage>857</fpage>
                  <lpage>862</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF00400362</pub-id>
                  <?supplied-pmid 8405758?>
                  <pub-id pub-id-type="pmid">8405758</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-nutrients-11-02697">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Little</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Pilichiewicz</surname>
                      <given-names>A.N.</given-names>
                    </name>
                    <name>
                      <surname>Russo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Phillips</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Nauck</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Feinle–Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of intravenous glucagon–like peptide–1 on gastric emptying and intragastric distribution in healthy subjects: Relationships with postprandial glycemic and insulinemic responses</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2006</year>
                  <volume>91</volume>
                  <fpage>1916</fpage>
                  <lpage>1923</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2005-2220</pub-id>
                  <pub-id pub-id-type="pmid">16492694</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-nutrients-11-02697">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heddle</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Collins</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Dent</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Read</surname>
                      <given-names>N.W.</given-names>
                    </name>
                    <name>
                      <surname>Chatterton</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Houghton</surname>
                      <given-names>L.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion</article-title>
                  <source>J. Gastroenterol. Hepatol.</source>
                  <year>1989</year>
                  <volume>4</volume>
                  <fpage>437</fpage>
                  <lpage>447</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1440-1746.1989.tb01741.x</pub-id>
                  <pub-id pub-id-type="pmid">2491209</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-nutrients-11-02697">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moran-Ramos</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Tovar</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Torres</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Diet: Friend or foe of enteroendocrine cells-how it interacts with enteroendocrine cells</article-title>
                  <source>Adv. Nutr.</source>
                  <year>2012</year>
                  <volume>3</volume>
                  <fpage>8</fpage>
                  <lpage>20</lpage>
                  <pub-id pub-id-type="doi">10.3945/an.111.000976</pub-id>
                  <pub-id pub-id-type="pmid">22332097</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-nutrients-11-02697">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ryan</surname>
                      <given-names>A.T.</given-names>
                    </name>
                    <name>
                      <surname>Luscombe-Marsh</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Saies</surname>
                      <given-names>A.A.</given-names>
                    </name>
                    <name>
                      <surname>Little</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Standfield</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean men</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>2013</year>
                  <volume>98</volume>
                  <fpage>300</fpage>
                  <lpage>311</lpage>
                  <pub-id pub-id-type="doi">10.3945/ajcn.113.061333</pub-id>
                  <pub-id pub-id-type="pmid">23803895</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-nutrients-11-02697">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Prentki</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Madiraju</surname>
                      <given-names>S.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Glycerolipid/free fatty acid cycle and islet beta-cell function in health, obesity and diabetes</article-title>
                  <source>Mol. Cell. Endocrinol.</source>
                  <year>2012</year>
                  <volume>353</volume>
                  <fpage>88</fpage>
                  <lpage>100</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mce.2011.11.004</pub-id>
                  <pub-id pub-id-type="pmid">22108437</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-nutrients-11-02697">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Newsholme</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bender</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Kiely</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Brennan</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Amino acid metabolism, insulin secretion and diabetes</article-title>
                  <source>Biochem. Soc. Trans.</source>
                  <year>2007</year>
                  <volume>35</volume>
                  <fpage>1180</fpage>
                  <lpage>1186</lpage>
                  <pub-id pub-id-type="doi">10.1042/BST0351180</pub-id>
                  <pub-id pub-id-type="pmid">17956307</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-nutrients-11-02697">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steinert</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Luscombe-Marsh</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Little</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Standfield</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Otto</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2014</year>
                  <volume>99</volume>
                  <fpage>3275</fpage>
                  <lpage>3284</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2014-1943</pub-id>
                  <?supplied-pmid 24926954?>
                  <pub-id pub-id-type="pmid">24926954</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-nutrients-11-02697">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Little</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Feltrin</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Smout</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Rades</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Pilichiewicz</surname>
                      <given-names>A.N.</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men</article-title>
                  <source>Am. J. Physiol. Regul. Integr. Comp. Physiol.</source>
                  <year>2005</year>
                  <volume>289</volume>
                  <fpage>R1090</fpage>
                  <lpage>R1098</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpregu.00290.2005</pub-id>
                  <?supplied-pmid 15961531?>
                  <pub-id pub-id-type="pmid">15961531</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-nutrients-11-02697">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ullrich</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Fitzgerald</surname>
                      <given-names>P.C.E.</given-names>
                    </name>
                    <name>
                      <surname>Giesbertz</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Steinert</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of intragastric administration of tryptophan on the blood glucose response to a nutrient drink and energy intake, in lean and obese men</article-title>
                  <source>Nutrients</source>
                  <year>2018</year>
                  <volume>10</volume>
                  <elocation-id>463</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/nu10040463</pub-id>
                  <?supplied-pmid 29642492?>
                  <pub-id pub-id-type="pmid">29642492</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-nutrients-11-02697">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Checklin</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Stevens</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Rayner</surname>
                      <given-names>C.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes</article-title>
                  <source>Diabetologia</source>
                  <year>2013</year>
                  <volume>56</volume>
                  <fpage>1236</fpage>
                  <lpage>1242</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00125-013-2876-2</pub-id>
                  <?supplied-pmid 23471488?>
                  <pub-id pub-id-type="pmid">23471488</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-nutrients-11-02697">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vahl</surname>
                      <given-names>T.P.</given-names>
                    </name>
                    <name>
                      <surname>Tauchi</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Durler</surname>
                      <given-names>T.S.</given-names>
                    </name>
                    <name>
                      <surname>Elfers</surname>
                      <given-names>E.E.</given-names>
                    </name>
                    <name>
                      <surname>Fernandes</surname>
                      <given-names>T.M.</given-names>
                    </name>
                    <name>
                      <surname>Bitner</surname>
                      <given-names>R.D.</given-names>
                    </name>
                    <name>
                      <surname>Ellis</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Woods</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Seeley</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Herman</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats</article-title>
                  <source>Endocrinology</source>
                  <year>2007</year>
                  <volume>148</volume>
                  <fpage>4965</fpage>
                  <lpage>4973</lpage>
                  <pub-id pub-id-type="doi">10.1210/en.2006-0153</pub-id>
                  <?supplied-pmid 17584962?>
                  <pub-id pub-id-type="pmid">17584962</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-nutrients-11-02697">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nishizawa</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Moore</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Shiota</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gustavson</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Snead</surname>
                      <given-names>W.L.</given-names>
                    </name>
                    <name>
                      <surname>Neal</surname>
                      <given-names>D.W.</given-names>
                    </name>
                    <name>
                      <surname>Cherrington</surname>
                      <given-names>A.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2003</year>
                  <volume>284</volume>
                  <fpage>E1027</fpage>
                  <lpage>E1036</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00503.2002</pub-id>
                  <?supplied-pmid 12569088?>
                  <pub-id pub-id-type="pmid">12569088</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-nutrients-11-02697">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stewart</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Keast</surname>
                      <given-names>R.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Fatty acid detection during food consumption and digestion: Associations with ingestive behavior and obesity</article-title>
                  <source>Prog. Lipid Res.</source>
                  <year>2011</year>
                  <volume>50</volume>
                  <fpage>225</fpage>
                  <lpage>233</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.plipres.2011.02.002</pub-id>
                  <pub-id pub-id-type="pmid">21356242</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-nutrients-11-02697">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>San Gabriel</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Uneyama</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Amino acid sensing in the gastrointestinal tract</article-title>
                  <source>Amino Acids</source>
                  <year>2013</year>
                  <volume>45</volume>
                  <fpage>451</fpage>
                  <lpage>461</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00726-012-1371-2</pub-id>
                  <pub-id pub-id-type="pmid">22865248</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-nutrients-11-02697">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steensels</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Depoortere</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Chemoreceptors in the gut</article-title>
                  <source>Annu. Rev. Physiol.</source>
                  <year>2018</year>
                  <volume>80</volume>
                  <fpage>117</fpage>
                  <lpage>141</lpage>
                  <pub-id pub-id-type="doi">10.1146/annurev-physiol-021317-121332</pub-id>
                  <pub-id pub-id-type="pmid">29029594</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-nutrients-11-02697">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McVeay</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Fitzgerald</surname>
                      <given-names>P.C.E.</given-names>
                    </name>
                    <name>
                      <surname>Ullrich</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Steinert</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of intraduodenal administration of lauric acid and L-tryptophan, alone and combined, on gut hormones, pyloric pressures, and energy intake in healthy men</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>2019</year>
                  <volume>109</volume>
                  <fpage>1335</fpage>
                  <lpage>1343</lpage>
                  <pub-id pub-id-type="doi">10.1093/ajcn/nqz020</pub-id>
                  <pub-id pub-id-type="pmid">31051504</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-nutrients-11-02697">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stunkard</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Messick</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger</article-title>
                  <source>J. Pyschosom. Res.</source>
                  <year>1985</year>
                  <volume>29</volume>
                  <fpage>71</fpage>
                  <lpage>83</lpage>
                  <pub-id pub-id-type="doi">10.1016/0022-3999(85)90010-8</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-nutrients-11-02697">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Feltrin</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Little</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Horowitz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rades</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Feinle-Bisset</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of lauric acid on upper gut motility, plasma cholecystokinin and peptide YY, and energy intake are load, but not concentration, dependent in humans</article-title>
                  <source>J. Physiol.</source>
                  <year>2007</year>
                  <volume>581</volume>
                  <fpage>767</fpage>
                  <lpage>777</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.2007.129650</pub-id>
                  <?supplied-pmid 17331985?>
                  <pub-id pub-id-type="pmid">17331985</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-nutrients-11-02697">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heddle</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Dent</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Toouli</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Read</surname>
                      <given-names>N.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Topography and measurement of pyloric pressure waves and tone in humans</article-title>
                  <source>Am. J. Physiol.</source>
                  <year>1988</year>
                  <volume>255</volume>
                  <fpage>G490</fpage>
                  <lpage>G497</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpgi.1988.255.4.G490</pub-id>
                  <?supplied-pmid 3140675?>
                  <pub-id pub-id-type="pmid">3140675</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-nutrients-11-02697">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ardiansyah</surname>
                    </name>
                    <name>
                      <surname>Shirakawa</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Inagawa</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Koseki</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Komai</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation of blood pressure and glucose metabolism induced by L-tryptophan in stroke-prone spontaneously hypertensive rats</article-title>
                  <source>Nutr. Metab.</source>
                  <year>2011</year>
                  <volume>8</volume>
                  <fpage>45</fpage>
                  <pub-id pub-id-type="doi">10.1186/1743-7075-8-45</pub-id>
                  <?supplied-pmid 21831334?>
                  <pub-id pub-id-type="pmid">21831334</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-nutrients-11-02697">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holst</surname>
                      <given-names>J.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The physiology of glucagon-like peptide-1</article-title>
                  <source>Physiol. Rev.</source>
                  <year>2007</year>
                  <volume>87</volume>
                  <fpage>1409</fpage>
                  <lpage>1439</lpage>
                  <pub-id pub-id-type="doi">10.1152/physrev.00034.2006</pub-id>
                  <?supplied-pmid 17928588?>
                  <pub-id pub-id-type="pmid">17928588</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-nutrients-11-02697">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nauck</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Kleine</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Orskov</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Holst</surname>
                      <given-names>J.J.</given-names>
                    </name>
                    <name>
                      <surname>Willms</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Creutzfeldt</surname>
                      <given-names>W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide-1 (7–36 amide) in type 2 (non-insulin-dependent) diabetic patients</article-title>
                  <source>Diabetologia</source>
                  <year>1993</year>
                  <volume>36</volume>
                  <fpage>741</fpage>
                  <lpage>744</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF00401145</pub-id>
                  <pub-id pub-id-type="pmid">8405741</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-nutrients-11-02697">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Degn</surname>
                      <given-names>K.B.</given-names>
                    </name>
                    <name>
                      <surname>Brock</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Juhl</surname>
                      <given-names>C.B.</given-names>
                    </name>
                    <name>
                      <surname>Djurhuus</surname>
                      <given-names>C.B.</given-names>
                    </name>
                    <name>
                      <surname>Grubert</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Fineman</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schmitz</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia</article-title>
                  <source>Diabetes</source>
                  <year>2004</year>
                  <volume>53</volume>
                  <fpage>2397</fpage>
                  <lpage>2403</lpage>
                  <pub-id pub-id-type="doi">10.2337/diabetes.53.9.2397</pub-id>
                  <pub-id pub-id-type="pmid">15331551</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-nutrients-11-02697">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lamont</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Kwan</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Gaisano</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Drucker</surname>
                      <given-names>D.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice</article-title>
                  <source>J. Clin. Investig.</source>
                  <year>2012</year>
                  <volume>122</volume>
                  <fpage>388</fpage>
                  <lpage>402</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI42497</pub-id>
                  <pub-id pub-id-type="pmid">22182839</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-nutrients-11-02697">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stefanaki</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Peppa</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mastorakos</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Chrousos</surname>
                      <given-names>G.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Examining the gut bacteriome, virome, and mycobiome in glucose metabolism disorders: Are we on the right track?</article-title>
                  <source>Metabolism</source>
                  <year>2017</year>
                  <volume>73</volume>
                  <fpage>52</fpage>
                  <lpage>66</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.metabol.2017.04.014</pub-id>
                  <pub-id pub-id-type="pmid">28732571</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-nutrients-11-02697">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>David</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Maurice</surname>
                      <given-names>C.F.</given-names>
                    </name>
                    <name>
                      <surname>Carmody</surname>
                      <given-names>R.N.</given-names>
                    </name>
                    <name>
                      <surname>Gootenberg</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Button</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Wolfe</surname>
                      <given-names>B.E.</given-names>
                    </name>
                    <name>
                      <surname>Ling</surname>
                      <given-names>A.V.</given-names>
                    </name>
                    <name>
                      <surname>Devlin</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Varma</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Fischbach</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Diet rapidly and reproducibly alters the human gut microbiome</article-title>
                  <source>Nature</source>
                  <year>2014</year>
                  <volume>505</volume>
                  <fpage>559</fpage>
                  <lpage>563</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature12820</pub-id>
                  <pub-id pub-id-type="pmid">24336217</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="nutrients-11-02697-f001" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Plasma glucose (<bold>A</bold>), insulin (<bold>B</bold>), and glucagon (<bold>C</bold>) concentrations during duodenal administration of lauric acid (“C12”; 0.3 kcal/min), L-tryptophan (“Trp”; 0.1 kcal/min), a combination of C12 and Trp (“C12+Trp”; 0.4 kcal/min), or isotonic saline (“control”), for 90 min and, at <italic>t</italic> = 120 min, after a buffet-meal. Data (AUCs of glucose and hormone profiles) were analysed using one-way repeated measures ANOVAs, followed, if significant, by post hoc paired comparisons, adjusted for multiple comparisons by Bonferroni’s correction. Post-meal (<italic>t =</italic> 120 min) and pre-meal (<italic>t</italic> = 90 min) values were compared using paired <italic>t</italic>-tests. * <italic>p</italic> &lt; 0.05 vs. control; # <italic>p</italic> &lt; 0.05 all treatments vs corresponding values at <italic>t</italic> = 90 min; α <italic>p</italic> &lt; 0.05 C12+Trp and Trp vs. corresponding values at <italic>t</italic> = 90 min. Data are means ± SEM, <italic>n</italic> = 16, except insulin, <italic>n</italic> = 15.</p>
              </caption>
              <graphic xlink:href="nutrients-11-02697-g001"/>
            </fig>
            <table-wrap id="nutrients-11-02697-t001" orientation="portrait" position="float">
              <object-id pub-id-type="pii">nutrients-11-02697-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Plasma glucose, insulin and glucagon concentrations, and insulin-to-glucose ratio during duodenal administration of lauric acid (“C12”; 0.3 kcal/min), L-tryptophan (“Trp”; 0.1 kcal/min), a combination of C12 and Trp (“C12+Trp”; 0.4 kcal/min), or isotonic saline (“control”), for 90 min.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">C12</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Trp</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">C12+Trp</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>p</italic> Value</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma glucose AUC (mmol/L*min)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">426 ± 7</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">414 ± 5 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">422 ± 4</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">410 ± 5 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.05</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma glucose nadir (mmol/L)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.7 ± 0.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 ± 0.1 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.6 ± 0.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.4 ± 0.1 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.05</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma insulin AUC (mU/L*min)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">210 ± 35</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">246 ± 28</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">266 ± 39</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">318 ± 47 *</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.05</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma glucagon AUC (pg/mL*min)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3849 ± 457</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4146 ± 690</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3675 ± 492</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3787 ± 375</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NS</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insulin-to-glucose ratio</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5 ± 0.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6 ± 0.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6 ± 0.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8 ± 0.1 <sup>#</sup></td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.01</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Data are expressed as means ± standard error of the mean (SEM), <italic>n</italic> = 16 for glucose data and glucagon, <italic>n</italic> = 15 for insulin and insulin-to-glucose ratio. Repeated-measures analysis of variance (ANOVA), with treatment as a factor, was used to determine main treatment effects; post hoc comparisons (with Bonferroni correction) were performed when the ANOVA revealed significant effects. * <italic>p</italic> &lt; 0.05 vs. control; <sup>#</sup>
<italic>p</italic> &lt; 0.01 vs. control; AUC, area under the curve; NS, not significant.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
